The Valley Desk

NCT02609230 · Interventional trial

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Overall registry status Completed

Phase 1

Conditions Advanced Solid Tumors, Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov